Spyre Therapeutics (SYRE) Current Deferred Revenue (2016 - 2023)
Spyre Therapeutics' Current Deferred Revenue came in at $930,000 for Q2 2023, up 219.6% from $291,000 a year earlier and up 207.9% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Current Deferred Revenue (2016 - 2023) Analysis & Trends
At the end of FY2022, Spyre Therapeutics' Current Deferred Revenue was $517,000, down 78.1% from FY2021.
- Current Deferred Revenue carries a five-year compound annual growth rate of 91.6% (FY2017 to FY2022).
- Going back by year, Current Deferred Revenue was $2.36 million in FY2021.
- The Q2 2023 figure represents the highest quarterly Current Deferred Revenue since Q1 2022.
- Year-over-year, Current Deferred Revenue increased in 1 of the last six quarters, with an average decline of 36.2%.
- Business Quant data shows SYRE's Current Deferred Revenue at $302,000 (Q1 2023), $517,000 (Q4 2022) and $505,000 (Q3 2022) in the three quarters before Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 930,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 517,000.00 |
| Sep 30, 2022 | 505,000.00 |
| Jun 30, 2022 | 291,000.00 |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 4.79 Mn |
| Jun 30, 2021 | 5.53 Mn |
| Mar 31, 2021 | 19.23 Mn |
| Dec 31, 2017 | 20,000.00 |
| Sep 30, 2017 | 50,000.00 |
| Jun 30, 2017 | 71,000.00 |
| Mar 31, 2017 | 51,000.00 |
| Dec 31, 2016 | 71,000.00 |
| Sep 30, 2016 | 181,000.00 |
API Access
Spyre Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();